Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Net Asset Quality Index
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd net asset quality index. Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Net Asset Quality Index of 25.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥6.39 Billion minus total liabilities of CN¥4.79 Billion yields net assets of CN¥1.60 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Hunan Dajiaweikang Pharmaceutical Indust (301126) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2025)
Net asset quality index of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2025. This chart shows how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the index stands at 25.1%, representing net assets of CN¥1.60 Billion against total assets of CN¥6.39 Billion CNY. Check Hunan Dajiaweikang Pharmaceutical Indust tangible equity quality to evaluate the tangible quality of the company's equity base.
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Net Asset Quality Index by Year (2019–2025)
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd net asset quality index by year from 2019 to 2025. The table below presents the year-by-year Net Asset Quality Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Hunan Dajiaweikang Pharmaceutical Indust.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 25.1% | CN¥1.59 Billion | CN¥6.34 Billion | CN¥4.74 Billion | ▼ -4.8 pp |
| 2024 | 29.9% | CN¥1.85 Billion | CN¥6.18 Billion | CN¥4.33 Billion | ▼ -3.8 pp |
| 2023 | 33.8% | CN¥1.78 Billion | CN¥5.28 Billion | CN¥3.50 Billion | ▼ -12.5 pp |
| 2022 | 46.2% | CN¥1.82 Billion | CN¥3.93 Billion | CN¥2.11 Billion | ▼ -9.9 pp |
| 2021 | 56.1% | CN¥1.68 Billion | CN¥2.99 Billion | CN¥1.32 Billion | ▲ +8.8 pp |
| 2020 | 47.3% | CN¥1.04 Billion | CN¥2.20 Billion | CN¥1.16 Billion | ▼ -1.2 pp |
| 2019 | 48.5% | CN¥977.24 Million | CN¥2.02 Billion | CN¥1.04 Billion | — |